Financhill
Back

AnaptysBio Vs. Regeneron Pharmaceuticals Industry Stock Comparison

Sell
26

ANAB
AnaptysBio

Last Price:
22.28
Seasonality Move:
24.05%
Sell
39

REGN
Regeneron Pharmaceuticals

Last Price:
737.85
Seasonality Move:
14.6%
Sell
26
AnaptysBio (ANAB) is a Sell

Is AnaptysBio a Buy, Sell or Hold?

  • The current AnaptysBio [ANAB] share price is $21.17. The Score for ANAB is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • ANAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $744.50. The Score for REGN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ANAB Stock Price Chart

What is AnaptysBio's stock price today?

  • The AnaptysBio share price today is $21.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ANAB is experiencing slight buying pressure.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $744.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight selling pressure.

ANAB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.96 Sell
Relative Strength Index (14 RSI): 37.43 Sell
Chaikin Money Flow: 121522 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.87 - 30.75) Sell
Bollinger Bands (100): (26.04 - 37.66) Sell

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -61.44 Sell
Relative Strength Index (14 RSI): 13.71 Sell
Chaikin Money Flow: -202813 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (775.32 - 928.52) Sell
Bollinger Bands (100): (911.38 - 1161.56) Sell

ANAB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.22 Buy
20-day SMA: 22.39 Sell
50-day SMA: 29.84 Sell
200-day SMA: 27.71 Sell
8-day EMA: 20.58 Buy
20-day EMA: 22.94 Sell
50-day EMA: 27.37 Sell
200-day EMA: 27.79 Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 769.89 Sell
20-day SMA: 825.31 Sell
50-day SMA: 956.7 Sell
200-day SMA: 1002.38 Sell
8-day EMA: 768.55 Sell
20-day EMA: 823.78 Sell
50-day EMA: 920.48 Sell
200-day EMA: 975.85 Sell

AnaptysBio Earnings Growth & ANAB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.24 per share, and a decrease next year of $0.47 per share.

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.42 per share, and an increase next year of $0.41 per share.

AnaptysBio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):